Martin Marietta has appointed Thomas Pike as an independent member to its board of directors, where he will serve on the management development and compensation committee.
Ward Nye, chairman of Martin Marietta, says: “Tom brings significant experience in global M&A, strategic, operational, technology and risk management leadership to the Martin Marietta board from his role as CEO and a member of the board of directors of Quintiles, a Fortune 500 company before its merger with IMS Health. In addition, Tom is familiar with both Colorado and North Carolina, key states in Martin Marietta’s business.”
Pike served as chief executive officer and a member of the board of directors of Quintiles Transnational Holdings from April 2016 until its merger in December 2016 with IMS Health, now known as IQVIA. Prior to that, Pike spent 22 years at Accenture, a global professional services company, where he worked at chief risk officer and managing director of the North America health and products business areas. He previously served as the global chief operating officer for Accenture’s Resources operating group and had also served as Accenture’s chief strategy officer. Since leaving Accenture in December 2009 and until joining Quintiles in April 2012, Pike was involved with a range of start-ups in the technology and healthcare sectors. Early in his career, Mr. Pike was a consultant at McKinsey & Company.